Welcome to a CDMO where science meets service excellence, where innovation merges with reliability
Revolutionise your clinical development with our expert development & manufacturing services for innovative biomolecules
We support your project from R&D to in-market supply
Start your CMC journey confidently with our tailored development and GMP manufacturing services
R&D services
Custom production services with all prominent expression systems providing recombinant proteins for your R&D studies.
Process Development
Developing top-tier manufacturing processes for a range of molecules: proteins, antibodies, bioconjugates, and nanodrugs.
Analytical Development
Phase-appropriate method development for mammalian, microbial, and bioconjugate manufacturing.
GMP Manufacturing
Our top-notch GMP facilities manufacture preclinical, clinical, and small commercial batches of innovative therapies.
Fill & Finish
Our in-house aseptic filling supports liquid drug product manufacturing, accelerating your path to clinic and market.
Project Management
From start to finish, our expert team of scientists guides you seamlessly through every step of your CMC journey.
Client stories: what they were looking for in a CDMO
We’ve helped our customers develop and manufacture innovative therapies for more than 20 years.
“The team at BrainEver really valued working with GTP Bioways. They quickly captured our needs and came back with suitable solutions that fit our tight timelines. Their experience in protein production was, without question, a strong asset in moving from academia research into the inital development phases.”
Hubert Mechain, BrainEver
“With GTP Bioways, Osivax found a reliable GMP-compliant formulation and aspetic filling service provider. Their understanding of our needs, commitment to quality and customer-oriented focus were appreciated. They are also our partners for some R&D and analytical activities with relevant and problem-solving scientific discussions”
Imène Turki, Osivax
“We are happy to work with GTP Bioways for our very first clinical trial. This collaboration is a key point in the preparation of our clinical product before its administration to patients. With their brand-new facilities in Toulouse and their aseptic fill and finish operations, GTP Bioways shows all the guarantees requested for our lead anticancer compound ABD-3001 during our first-in-human clinical trial in acute myeloid leukemia upcoming soon. During the set-up of our GMP production, GTP Bioways team has been quite flexible and reactive to our needs “
Ismail Ceylan, Founder and CEO of Advanced Biodesign
“At European Vaccine Initiative, we have found GTP Bioways to be a very reliable partner. I specifically appreciated the intelligence their team put in the process development, going beyond merely executing our instructions.”
Nicolas Havelange, EVI
“GTP Bioways is a flexible and reactive company with an high understanding of the development challenges for a biotech. Collaboration is easy, the teams are open to scientific discussions and collaborate with us about how to solve problems together. Very good partner for the development of new projects!”
Judith Greciet, Onxeo
“GTP Bioways is technically sound and client-oriented. We appreciated the mutual understanding between GTP Bioways and Xenothera and how GTP Bioways could adapt its offer to our needs.”
Bernard Vanhove, Xenothera
From R&D to commercial production: our expertise spans all stages of biotherapeutics development
Years as a CDMO
Years' expertise in aseptic filling
Clients served worldwide
Protein programmes managed
GTP Bioways – your partner for biologics development and manufacturing
Our process development and manufacturing facilities sit in the heart of Europe.
Saint-Julien
mAb & ADC GMP Manufacturing
Toulouse
Cell Line Development, GMP Manufacturing & Fill & Finish
Labège
Microbial & Mammalian Process Development
Veyre-Monton
HCP Risk Management & Immunoassays Development
From our blog:Our biologics CDMO experience
5 Key Steps in GMP Cell Line Development Process
Why Cell Line Development Is Essential for Biologics Manufacturing Cell line development is one of the most critical stages in the creation of biologics such as monoclonal antibodies, recombinant...
Antibody-Drug Conjugates (ADC): From Concept to GMP Manufacturing
Antibody-Drug Conjugates (ADC): From Concept to GMP Manufacturing Antibody-drug conjugates (ADCs) represent a groundbreaking class of targeted therapies that combine the specificity of monoclonal...
Optimizing Process Development for Monoclonal Antibodies
Optimizing Process Development for Monoclonal Antibodies: Key Considerations for Clinical Success Monoclonal antibodies (mAbs) have become one of the most prominent therapeutic modalities in...
